Name: Erlizumab Biosimilar, Research Grade
SKU: ARP-B00085
Availability: InStock

Epcoritamab Biosimilar, Research Grade

Catalog # : ARP-B00096

Target : B-lymphocytesurfaceantigenB1, Membrane-spanning4-domainssubfamilyAmember1, MS4A1, LeukocytesurfaceantigenLeu-16, B-lymphocyteantigenCD20, Bp35, CD20, T3E, T-cellsurfaceantigenT3/Leu-4epsilonchain, CD3e, CD3E, T-cellsurfaceglycoproteinCD3epsilonchain

Reactivity : Human

From $349.00

See Details

Epcoritamab ELISA Kit

Catalog # : ARP-BS-164

Sensitivity : 0.156 μg/ml

Detection Range : 0.31-5 μg/mL

From $1,459.00

See Details

Epitumomab Biosimilar, Research Grade

Catalog # : ARP-B00225

Target : PEMT, CA15-3, H23AG, Peanut-reactiveurinarymucin, PEM, EMA, Cancerantigen15-3, MUC-1, Episialin, MUC1-CT, MUC1-beta, Tumor-associatedmucin, CD227, Polymorphicepithelialmucin, KL-6, MUC1-alpha, MUC1, PUM, KrebsvondenLungen-6, MUC1-NT, Tumor-associatedepithelialmembraneantigen, Mucin-1, Breastcarcinoma-associatedantigenDF3, Carcinoma-associatedmucin

Reactivity : Human

From $389.00

See Details

Epratuzumab Biosimilar, Research Grade

Catalog # : ARP-B02215

Target : Sialicacid-bindingIg-likelectin2, Siglec-2, CD22, T-cellsurfaceantigenLeu-14, BL-CAM, SIGLEC2, B-lymphocytecelladhesionmolecule, B-cellreceptorCD22

Reactivity : Human

From $349.00

See Details

Epratuzumab Biosimilar, Research Grade

Catalog # : ARP-B00101

Target : Sialicacid-bindingIg-likelectin2, Siglec-2, CD22, T-cellsurfaceantigenLeu-14, BL-CAM, SIGLEC2, B-lymphocytecelladhesionmolecule, B-cellreceptorCD22

Reactivity : Human

From $349.00

See Details

Eptinezumab Biosimilar, Research Grade

Catalog # : ARP-B00645

Target : CCP, PDN-21, CALCA, Calcitonincarboxyl-terminalpeptide, Calcitonin, CALC1, Calcitoningene-relatedpeptideII, CALCB, Calcitoningene-relatedpeptide2, Beta-CGRP, CALC2, CGRP-II, Beta-typeCGRP

Reactivity : Human

From $349.00

See Details

Eramkafusp Alfa Biosimilar, Research Grade

Catalog # : ARP-B02059

Target : B-lymphocytesurfaceantigenB1, Membrane-spanning4-domainssubfamilyAmember1, MS4A1, LeukocytesurfaceantigenLeu-16, B-lymphocyteantigenCD20, Bp35, CD20, Interferonalpha-2, IFNA2C, IFNA2, IFN-alpha-2, LeIFA, IFNA2A, IFNA2B, Interferonalpha-A

Reactivity : Human

From $499.00

See Details

Erenumab Biosimilar, Research Grade

Catalog # : ARP-B00630

Target : CGRPtype1receptor, CGRPR, Calcitoninreceptor-likereceptor, CALCRL, Calcitoningene-relatedpeptidetype1receptor

Reactivity : Human

From $349.00

See Details

Erfonrilimab Biosimilar, Research Grade

Catalog # : ARP-B00673

Target : CD152, CytotoxicT-lymphocyteprotein4, CTLA-4, CTLA4, CytotoxicT-lymphocyte-associatedantigen4, B7-H1, Programmedcelldeath1ligand1, PDCD1ligand1, PDCD1L1, B7homolog1, PDCD1LG1, PDL1, hPD-L1, Programmeddeathligand1, B7H1, PD-L1, CD274

Reactivity : Human

From $499.00

See Details

Erlizumab Biosimilar, Research Grade

Catalog # : ARP-B00085

Target : ComplementreceptorC3subunitbeta, CellsurfaceadhesionglycoproteinsLFA-1/CR3/p150, 95subunitbeta, Integrinbeta-2, MFI7, CD18, ITGB2

Reactivity : Human

From $349.00

See Details

Biopharmaceutical Development

Information

Customer Service

Our Partners

Biopharmaceutical Development

Categories